Drug

Heartworm Prevention: For prevention of heartworm disease, Topical Solution for Dogs should be administered at one-month intervals. Topical Solution for Dogs may be administered year-round or at a minimum should start one month before the first expected exposure to mosquitoes and should continue at monthly intervals until one month after the last exposure to mosquitoes. If a dose is missed and a 30-day interval between doses is exceeded, administer Topical Solution for Dogs immediately and resume the monthly dosing schedule. When replacing another heartworm preventative product in a heartworm prevention program, the first treatment with Topical Solution for Dogs should be given within one month of the last dose of the former medication.

Treatment of Circulating Microfilaria: For the treatment of circulating D. immitis microfilaria in heartworm-positive dogs, Topical Solution for Dogs should be administered at one-month intervals. Treatment with an approved adulticide therapy is recommended because Topical Solution for Dogs is not effective for the treatment .

Flea Treatment: For the treatment of flea infestations, Topical Solution for Dogs should be administered at one-month intervals. If the dog is already infested with fleas when the first dose of Topical Solution for Dogs is administered, adult fleas on the dog will be killed. However, reinfestation from the emergence of preexisting pupae in the environment may continue to occur for six weeks or longer after treatment is initiated. Dogs treated with imidacloprid, including those with pre-existing flea allergy dermatitis have shown clinical improvement as a direct result of elimination of fleas from the dog.

Treatment and Control of Intestinal Nematode Infections: For the treatment and control of intestinal hookworm infections caused by Ancylostoma caninum and Uncinaria stenocephala (adults, immature adults and fourth stage larvae) and roundworm infections caused by Toxocara canis (adults and fourth stage larvae), and Toxascaris leonina (adults), and whipworm infections caused by Trichuris vulpis (adults), Topical Solution for Dogs should be administered once as a single topical dose.

Treatment and Control of Sarcoptic Mange: For the treatment and control of sarcoptic mange caused by Sarcoptes scabiei var. canis, Topical Solution for Dogs should be administered as a single topical dose. A second monthly dose may be administered if necessary.

Imidacloprid mechanism of action
Imidacloprid acts on the nicotinic acetylcholine receptors at the postsynaptic membranes in the flea, blocking acetylcholine and eventually leading to central nervous system impairment and death. The mechanism of action of imidacloprid is unique, differing from that of other insecticides (e.G., organophosphates, insect growth regulators) in that insect receptors are more sensitive than mammalian receptors to imidacloprid. this property was originally thought to make imidacloprid more advantageous than other commonly used agricultural insecticides on the market at the time, thereby limiting toxicity and negative effects on other organisms; however, we now know that this class of insecticides could have significant environmental effects.

Pharmacokinetics of imidacloprid
When administered orally, imidacloprid is absorbed rapidly and nearly completely from the dog's gastrointestinal tract and reaches effective concentration after about 1.3 hours. it is distributed throughout the tissues but does not accumulate in the tissues. Its penetration of the blood–brain barrier is poor, which leads to a more favorable safety profile. It is metabolized by the liver to an active metabolite and is eliminated in the urine (70% to 80%) and feces (20% to 30%); terminal half-life is about 2.2 hours.

When applied topically to dogs, imidacloprid is distributed across the skin by translocation and can be found in hair follicles, shed hair, and sebum. in dogs, systemic absorption of topical preparations seems to be minimal to none.

Imidacloprid dosing and administration
For active flea infestations, initial treatment with imidacloprid may be oral or topical. However, its use as monotherapy does not completely prevent infection with other parasites (e.G., heartworms and intestinal parasites). patients should be evaluated to ensure that they are receiving complete parasite prevention regimens with or without imidacloprid augmentation.
When topical formulations of imidacloprid are used, the veterinarian should consult individual product labels to be able to counsel clients on accurate restrictions, such as shampooing and water immersion, before and after application of these products.

Also known as amoxicillin and clavulanate potassium, is a synthetic, penicillin-type antibiotic used to treat infections caused by certain types of bacteria. It is used to treat skin infections, soft tissue infections, and periodontal disease. Clavulanic acid has been added to the amoxicillin to protect the antibiotic from certain enzymes that may destroy the amoxicillin before it can kill the bacteria.
It is used “off label” or “extra-label” to treat urinary tract infections and some other infections in dogs and cats. Many drugs are commonly prescribed for off-label use in veterinary medicine. In these instances, follow your veterinarian's directions and cautions very carefully.

Like all medications, clavecto can have side effects. However, these are relatively rare. During pre-market testing, clavecto was given to dogs at 5 times the recommended dose more frequently than recommended, with no side effects seen. When dogs and cats do get side effects, they might get:
Vomiting, drooling, or diarrhoea (1-2 out of 100 tablet-treated dogs and 1 in 200 spot-on-treated cats). These are mild and transient.
Decreased appetite (injection only) up to 1 in 100 dogs might suffer a decrease in appetite.
Tiredness, wobbliness, lethargy for the oral and spot-on products, less than 1 in 10,000 dogs and 1 in 100 cats get these symptoms. For the injectable clavecto, 1 in 100 dogs might seem tired.
Tremors, seizures less than 1 in 10,000 treated dogs gets muscle tremors and seizures. This side effect of clavecto is more common in cats ; 1 in 100 might get muscle tremors.
Skin reactions to spot on treatments (1-2 in 100 treated dogs and 2-3 in 100 treated cats)
Swelling at the injection site dogs getting a clavecto injection commonly get a swelling at the injection site (up to 1 in 10 dogs). This normally appears after a couple of weeks and is non-painful. It goes away on its own after another week or two.
Thought that clavecto lowers the seizure threshold, making seizures more likely. In most pets, you won’t notice a difference, but in pets already prone to seizures, this could be enough to tip them over the edge into seizures. Most dogs with this clavecto side effect recovered quickly.
While clavecto is generally considered safe, you should always discuss the pros and cons with your vet before using it. If you see side effects of clavecto, you should always inform your vet, whether it’s on this list or not. All suspected drug side effects should be reported to the veterinary medicines directorate (vmd). This allows the drug packaging and use to be changed after it is on the market, according to what real-life pets are experiencing.

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store the tablets at room temperature and away from excess heat and moisture (not in the bathroom). Keep liquid medication in the refrigerator, tightly closed, and dispose of any unused medication after 10 days.
It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach.